Your browser doesn't support javascript.
loading
Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015-2021.
Zhou, Yue; Naci, Huseyin; Chen, Dingyi; Bai, Lin; Shi, Luwen; Guan, Xiaodong; Wagner, Anita Katharina.
Afiliación
  • Zhou Y; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Naci H; Department of Pharmacy, Peking University People's Hospital, Beijing, China.
  • Chen D; Department of Health Policy, London School of Economics and Political Science, London, UK.
  • Bai L; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Shi L; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Guan X; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Wagner AK; International Research Center for Medicinal Administration, Peking University, Beijing, China.
BMJ Glob Health ; 8(9)2023 09.
Article en En | MEDLINE | ID: mdl-37775106
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BMJ Glob Health Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: BMJ Glob Health Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido